📋 Tender Overview
Contract awarded for Framework agreement for the supply of aflibercept lot-0001, title: aflibercept (40mg/1ml) - pre-filled syringe, description: registered for the following indications: 1. neovascular (wet) age-related macular degeneration (amd) 2. vision deterioration due to macular edema secondary to retinal vein occlusion 3. vision deterioration due to diabetic macular edema (dme) 4. vision deterioration due to myopic choroidal neovascularization (myopic cnv) lot-0003, title: aflibercept (40mg/1ml) - vial, description: aflibercept (40mg/1ml) - vial estimated value excluding vat: 10660.00 eur.Framework agreement for the supply of aflibercept
